Registered entities
Atyr Pharma Inc
Reg. No. 1339970United States
Atyr Pharma, Inc.
Reg. No. 203435077United States
Innovation
50 patent families (41 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 48,903 times.
| Year | Filings |
|---|---|
| 2015 | 29 |
| 2016 | 25 |
| 2017 | 32 |
| 2018 | 19 |
| 2019 | 18 |
| 2020 | 20 |
| 2021 | 15 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 10 |
| 2026 | 2 |
Social engagement
Social engagement: 7.1K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
16 investors on record; lead investors include Sofinnova Investments, Alta Partners, Polaris Partners, Domain Associates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 38% |
| Private equity | 2 | 13% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 7 | 44% |
Recent activity
25 Jun 2026
Event
1x1 meeting with aTyr management
23 Jun 2026
Event
Life Sciences Virtual Investor Forum
4 Jun 2026
Event
Jefferies Global Healthcare Conference